FMO5 and metabolic disease: It plays a key role in the pathogenesis of PAD and contributes to metabolic disorders, hypertension, and vascular endothelial damage through mechanisms such as mitochondrial complex dysfunction, NADPH oxidase activity, and e-NOS dysregulation (32).